364 related articles for article (PubMed ID: 33054046)
1. Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies.
Delgado J; Nadeu F; Colomer D; Campo E
Haematologica; 2020 Sep; 105(9):2205-2217. PubMed ID: 33054046
[TBL] [Abstract][Full Text] [Related]
2. Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
Kubuschok B; Trepel M
Expert Opin Drug Discov; 2017 Jul; 12(7):733-745. PubMed ID: 28494631
[TBL] [Abstract][Full Text] [Related]
3. Genomic and Epigenomic Alterations in Chronic Lymphocytic Leukemia.
Nadeu F; Diaz-Navarro A; Delgado J; Puente XS; Campo E
Annu Rev Pathol; 2020 Jan; 15():149-177. PubMed ID: 31977296
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal B cell lymphocytosis and "in situ" lymphoma.
Karube K; Scarfò L; Campo E; Ghia P
Semin Cancer Biol; 2014 Feb; 24():3-14. PubMed ID: 23999128
[TBL] [Abstract][Full Text] [Related]
5. Genomic Instability and Clonal Evolution in Chronic Lymphocytic Leukemia: Clinical Relevance.
Condoluci A; Rossi D
J Natl Compr Canc Netw; 2020 Dec; 19(2):227-233. PubMed ID: 33383567
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of DNA damage and alteration of the DNA damage response in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Popp HD; Flach J; Brendel S; Ruppenthal S; Kleiner H; Seifarth W; Schneider S; Schulze TJ; Weiss C; Wenz F; Hofmann WK; Fabarius A
Leuk Lymphoma; 2019 Mar; 60(3):795-804. PubMed ID: 30376743
[TBL] [Abstract][Full Text] [Related]
7. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.
Agathangelidis A; Ljungström V; Scarfò L; Fazi C; Gounari M; Pandzic T; Sutton LA; Stamatopoulos K; Tonon G; Rosenquist R; Ghia P
Haematologica; 2018 May; 103(5):865-873. PubMed ID: 29449433
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions.
Puente XS; Jares P; Campo E
Blood; 2018 May; 131(21):2283-2296. PubMed ID: 29666114
[TBL] [Abstract][Full Text] [Related]
10. What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
Scarfò L; Ghia P
Semin Oncol; 2016 Apr; 43(2):201-8. PubMed ID: 27040697
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
Ryder CB; Oduro KA; Moore EM
Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
[TBL] [Abstract][Full Text] [Related]
12. Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcome.
Criado I; Rodríguez-Caballero A; Gutiérrez ML; Pedreira CE; Alcoceba M; Nieto W; Teodosio C; Bárcena P; Romero A; Fernández-Navarro P; González M; Almeida J; Orfao A;
Haematologica; 2018 Jul; 103(7):1198-1208. PubMed ID: 29567775
[TBL] [Abstract][Full Text] [Related]
13. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis of chronic lymphocytic leukemia].
Fukuda T
Rinsho Ketsueki; 2015 Mar; 56(3):261-8. PubMed ID: 25876778
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.
Sutton LA; Rosenquist R
Haematologica; 2015 Jan; 100(1):7-16. PubMed ID: 25552678
[TBL] [Abstract][Full Text] [Related]
16. The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies.
Burger JA; Gribben JG
Semin Cancer Biol; 2014 Feb; 24():71-81. PubMed ID: 24018164
[TBL] [Abstract][Full Text] [Related]
17. Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis.
Defrancesco I; Zibellini S; Boveri E; Frigeni M; Ferretti VV; Rizzo E; Bonometti A; Capuano F; Candido C; Rattotti S; Tenore A; Picone C; Flospergher E; Zerbi C; Bergamini F; Fabbri N; Cristinelli C; Varettoni M; Paulli M; Arcaini L
Hematol Oncol; 2020 Dec; 38(5):689-697. PubMed ID: 32738175
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.
Ojha J; Secreto C; Rabe K; Ayres-Silva J; Tschumper R; Dyke DV; Slager S; Fonseca R; Shanafelt T; Kay N; Braggio E
Leukemia; 2014 Dec; 28(12):2395-8. PubMed ID: 25034147
[No Abstract] [Full Text] [Related]
19. Sequential development of monoclonal B cell lymphocytosis-derived small lymphocytic lymphoma and plasma cell leukemia.
Suzuki Y; Koya J; Ebisawa K; Abe H; Shinozaki-Ushiku A; Nakamura F; Kurokawa M
Ann Hematol; 2018 May; 97(5):917-919. PubMed ID: 29417202
[No Abstract] [Full Text] [Related]
20. Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis.
Gibson SE; Swerdlow SH; Ferry JA; Surti U; Dal Cin P; Harris NL; Hasserjian RP
Haematologica; 2011 Aug; 96(8):1144-52. PubMed ID: 21546505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
